Relationship between retinol-binding protein-4/adiponectin and leptin/adiponectin ratios with insulin resistance and inflammation

Metabolic Syndrome and Related Disorders

Volumn 12, Issue 4, 2014, Pages 227-230

  Jialal, Ishwarlal ^a,b   Adams Huet, Beverley ^c   Duong, Frank ^a   Smith, Gerred ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RETINOL BINDING PROTEIN 4; BIOLOGICAL MARKER; PLASMA RETINOL BINDING PROTEIN; RBP4 PROTEIN, HUMAN;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; AGED; BLOOD; BODY MASS; METABOLISM; MIDDLE AGED;

ADIPONECTIN; ADULT; AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LEPTIN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RETINOL-BINDING PROTEINS, PLASMA;

EID: 84899017094     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2014.0013     Document Type: Article

References (32)

1. Bassuk S, Rifai N, Ridker PM. High-sensitivity C-reactive protein: Clinical importance. Curr Probl Cardiol 2004;29: 439-493.
2. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004;27:1487-1495.
3. Mattu H, Randeva H. Roles of adipokines in cardiovascular disease. J Endocrinol 2013;216:T17-T36.
4. Bremer AA, Jialal I. Adipose tissue dysfunction in nascent metabolic syndrome. J Obes 2013;2013:393192.
5. Wang Z, Nakayama T. Inflammation, a link between obesity and cardiovascular disease. Mediators Inflamm 2010; 2010:535918.
6. Smith U, Yang X. Adipocytokine Dysregulation, Obesity and the Metabolic Syndrome. In: Byrne CD, Wild SH (eds). The Metabolic Syndrome, 2nd ed. Oxford, UK: Wiley- Blackwell; 2011: 229-244.
7. Bluher M. Clinical relevance of adipokines. Diabetes Metab J 2012;36:317-327.
8. Oda N, Imamura S, Fujita T, et al. The ratio of leptin to adiponectin can be used as an index of insulin resistance. Metabolism 2008;57:268-273.
9. Inoue M, Maehata E, Yano M, et al. Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type 2 diabetes. Metabolism 2005; 54:281-286.
10. Inoue M, Yano M, Yamakado M, et al. Relationship between the adiponectin-leptin ratio and parameters of insulin resistance in subjects without hyperglycemia. Metabolism 2006;55:1248-1254.
11. Satoh N, Naruse M, Usui T, et al. Leptin-to-adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients. Diabetes Care 2004;27:2488-2490.
12. Kotani K, Sakane N, Saiga K, et al. Leptin:adiponectin ratio as an atherosclerotic index in patients with type 2 diabetes: Relationship of the index to carotid intima-media thickness. Diabetologia 2005;48:2684-2686.
13. Kotani K, Sakane N. Leptin:adiponectin ratio and metabolic syndrome in the general Japanese population. Korean J Lab Med 2011;31:162-166.
14. Karakas M, Zierer A, Herder C, et al. Leptin, adiponectin, their ratio and risk of coronary heart disease: Results from the MONICA/KORA Augsburg Study 1984-2002. Atherosclerosis 2010;209:220-225.
15. Kappelle PJ, Dullaart RP, van Beek AP, et al. The plasma leptin/adiponectin ratio predicts first cardiovascular event in men: A prospective nested case-control study. Eur J Intern Med. 2012;23:755-759.
16. Kloting N, Fasshauer M, Dietrich A, et al. Insulin-sensitive obesity. Am J Physiol Endocrinol Metab 2010;299:E506- E515.
17. Yang Q, Graham T, Mody N. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005;436:356-362.
18. Graham T, Yang Q, Bluher M, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006;354:2552-2563.
19. Kotnik P, Fischer-Posovzsky P, Wabitsch M. RBP4: A controversial adipokine. Eur J Endocrinol 2011;165:703-711.
20. von Eynatten M, Lepper PM, Liu D, et al. Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease. Diabetologia 2007; 50:1930-1937.
21. Esteve E, Ricart W, Fernandez-Real JM. Adipocytokines and insulin resistance. Diabetes Care 2009;32(Suppl 2): S362-S367.
22. Jialal I, Devaraj S, Singh U, et al. Decreased number and impaired functionality of endothelial progenitor cells in subjects with metabolic syndrome: Implications for increased cardiovascular risk. Atherosclerosis 2010;211:297-302.
23. Bremer AA, Devaraj S, Afify A, et al. Adipose tissue dysregulation in patients with metabolic syndrome. J Clin Endocrinol Metab 2011;96:E1782-E1788.
24. Scherer P, Turer A. Adiponectin: Mechanistic insights and clinical implications. Diabetologia 2012;55:2319-2326.
25. Farjo K, Farjo R, Halsey S, et al. Retinol-binding protein 4 induces inflammation in human endothelial cells by an NADPH oxidase- and nuclear factor kappa B-dependent and retinol-independent mechanism. Mol Cell Biol 2012; 32:5103-5115.
26. Al-Daghri N, Al-Attas O, Alokail M, et al. Retinol binding protein-4 is associated with TNF-a and not insulin resistance in subjects with type 2 diabetes mellitus and coronary heart disease. Dis Markers 2009:26:135-140.
27. Sun Q, Kiernan U, Shi L, et al. Plasma retinol-binding protein 4 (RBP4) levels and risk of coronary heart disease: A prospective analysis among women in the nurses' health study. Circulation 2013;127:1938-1947.
28. Alkharfy K, Al-Daghri N, Vanhoutte P, et al. Serum retinol- binding protein 4 as a marker for cardiovascular disease in women. PLos One 2012;7:e48612.
29. Park SE, Kim DH, Lee JH, et al. Retinol-binding protein-4 is associated with endothelial dysfunction in adults with newly diagnosed type 2 diabetes mellitus. Atherosclerosis 2009;204:23-25.
30. Solini A, Stea F, Santini E, et al. Adipocytokine levels mark endothelial function in normotensive individuals. Cardiovasc Diabetol 2012;11:103.
31. Yoon JH, Park JK, Oh SS, et al. The ratio of serum leptin to adiponectin provides adjunctive information to the risk of metabolic syndrome beyond the homeostasis model assessment insulin resistance: The Korean Genomic Rural Cohort Study. Clin Chim Acta 2011;412:2199-2205.
32. Norata G, Raselli S, Grigore L, et al. Leptin:adiponectin ratio is an independent predictor of intima media thickness of the common carotid artery. Stroke 2007;38:2844-2846.